$7.26
0.030.35%
Last update: 10:12 AM
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/03/2024 | AMRX | Amneal Pharmaceuticals | FY | 2024 | $0.53 | $0.63 | $0.58 | $2.55B | $2.65B | $2.61B | Get Alert |
03/01/2024 | AMRX | Amneal Pharmaceuticals | FY | 2024 | $0.53 | $0.63 | $0.60 | $2.55B | $2.65B | $2.58B | Get Alert |
11/07/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.51 | $0.58 | $0.55 | $2.37B | $2.42B | $2.37B | Get Alert |
10/23/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.51 | $0.58 | $0.55 | $2.37B | $2.42B | $2.37B | Get Alert |
10/23/2023 | AMRX | Amneal Pharmaceuticals | Q3 | 2023 | — | — | — | $610.00M | $620.00M | $585.69M | Get Alert |
08/04/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.45 | $0.55 | $0.47 | $2.30B | $2.40B | $2.32B | Get Alert |
05/05/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.40 | $0.50 | $0.50 | $2.25B | $2.35B | $2.32B | Get Alert |
04/17/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.40 | $0.50 | $0.50 | $2.25B | $2.35B | $2.31B | Get Alert |
04/17/2023 | AMRX | Amneal Pharmaceuticals | Q1 | 2023 | — | — | — | $550.00M | $560.00M | $529.47M | Get Alert |
03/02/2023 | AMRX | Amneal Pharmaceuticals | FY | 2023 | $0.40 | $0.50 | $0.77 | $2.25B | $2.35B | $2.31B | Get Alert |
01/10/2023 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.65 | $0.70 | $0.66 | $2.15B | $2.25B | $2.18B | Get Alert |
11/04/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.65 | $0.70 | $0.68 | $2.15B | $2.25B | $2.20B | Get Alert |
08/05/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.65 | $0.70 | $0.81 | $2.15B | $2.25B | $2.17B | Get Alert |
05/04/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.80 | $0.85 | $0.84 | $2.15B | $2.25B | $2.19B | Get Alert |
03/02/2022 | AMRX | Amneal Pharmaceuticals | FY | 2022 | $0.80 | $0.85 | $0.90 | $2.15B | $2.25B | $2.17B | Get Alert |
01/11/2022 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.78 | $0.88 | $0.88 | $2.10B | $2.10B | $2.10B | Get Alert |
11/03/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.78 | $0.88 | $0.88 | $2.10B | $2.10B | $2.14B | Get Alert |
08/09/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.70 | $0.85 | $0.82 | $2.10B | $2.20B | $2.12B | Get Alert |
05/07/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.70 | $0.85 | $0.78 | $2.10B | $2.20B | $2.14B | Get Alert |
02/26/2021 | AMRX | Amneal Pharmaceuticals | FY | 2021 | $0.70 | $0.85 | $0.71 | $2.10B | $2.20B | $2.06B | Get Alert |
01/12/2021 | AMRX | Amneal Pharmaceuticals | FY | 2020 | $0.55 | $0.65 | $0.62 | $1.95B | $2.00B | $1.99B | Get Alert |
11/06/2020 | AMRX | Amneal Pharmaceuticals | FY | 2020 | $0.55 | $0.65 | $0.59 | $1.95B | $2.00B | $1.93B | Get Alert |
08/06/2020 | AMRX | Amneal Pharmaceuticals | FY | 2020 | $0.45 | $0.60 | $0.56 | $1.88B | $1.98B | $1.91B | Get Alert |
05/11/2020 | AMRX | Amneal Pharmaceuticals | FY | 2020 | $0.45 | $0.60 | $0.49 | $1.88B | $1.98B | $1.87B | Get Alert |
02/26/2020 | AMRX | Amneal Pharmaceuticals | FY | 2020 | $0.45 | $0.60 | $0.52 | $1.88B | $1.98B | $1.70B | Get Alert |
11/06/2019 | AMRX | Amneal Pharmaceuticals | FY | 2019 | $0.31 | $0.31 | $0.53 | — | — | — | Get Alert |
The last reported Earnings numbers were from May 3, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $0.53 and $0.63 versus the estimated EPS of $0.58.
Browse guidance and forecast on all stocks.